SpyGlass PharmaSGP

ListedNasdaq

Road to listing

Filed (S-1)01/16
1 amendment01/29
Last amendment
Declared effective01/30
Priced02/05
Listed02/06
Lock-up ends08/05
Passed

Offering terms

Offer price: $16.00
Shares offered: 9,375,000 sh
Raised: $150M
Exchange: Nasdaq
Lock-up: 180 days · prospectus

SpyGlass Pharma stock pagePrice and every trade

5% holders

			Form
Ra Capital Management	24.1%	8,022,639 sh	13D	02/17
New Enterprise Associates 17	22.2%	7,393,823 sh	13D	02/13
Vensana Capital I GP	9.9%	3,312,141 sh	13D	02/10
Sands Capital Life Sciences Pulse Fund III	7.8%	2,500,012 sh	13G passive	02/13
Gilde Healthcare Holding B.V.	6.6%	2,187,513 sh	13D	02/13
Samsara BioCapital	6.3%	2,109,953 sh	13G passive	02/17

Filings

424B4 final prospectus02/06
8-A12B exchange registration02/05
EFFECT notice of effectiveness01/30
S-1/A amendment01/29
S-1 registration statement01/16

SpyGlass Pharma SGP US IPO: offer price, listing date, lock-up expiry | Whalegun